Citadel Advisors’s Acer Therapeutics Inc ACER Stock Holding History
Bought
Maintained
Sold
Other funds holding ACER
YCM
NCM
HF
VF
HAIM
Citadel Advisors's ACER Position: Q3 2023 in Review
Citadel Advisors sold out of Acer Therapeutics Inc (ACER) in Q3 2023, closing a stake of 3,359 shares — an estimated $3.1K sold.
Citadel Advisors first reported a position in ACER in Q3 2013 and held it in 13 quarters. The position peaked at $191K in Q1 2021. 31 funds tracked by Wall St. Rank hold ACER as of Q3 2023.
- Citadel Advisors reported no remaining Acer Therapeutics Inc position as of Q3 2023 after selling out during the quarter.
- Citadel Advisors sold 3,359 Acer Therapeutics Inc shares in Q3 2023, an estimated $3.1K.
- Citadel Advisors first reported a position in Acer Therapeutics Inc in Q3 2013 and held it in 13 quarters.
- Citadel Advisors's Acer Therapeutics Inc position peaked at $191K in Q1 2021.
- 31 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2023.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.